This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Gelteq centers its technology on a proprietary, customizable gel platform designed for precise drugdelivery, supporting prescription drugs, nutraceuticals, pet care and sports supplements. Priced at $4.0
Highlights include expansion of biotech operations in Philadelphia, acquisition of a new pharma-device facility near Dublin, Ireland, and a new Center of Excellence for advanced drugdelivery and drug-device combination product assembly in Rockford, Illinois.
Lenz, Principal Medical Device Regulation Expert — For several years, FDA has requested that sponsors of drug or biologic led combination products identify essential performance requirements (EPRs) related to the device constituent in their applications. By Adrienne R. does not use this term.
Maculus plans to raise USD3 million on a USD8 million valuation for a 12-18 month period, including initial in-vivo animal studies and completion of in-vitro / in-vivo drug elution studies. Maculus achieved the breakthrough using a patented novel tunable biodegradable proprietary product, MacuBloc.
Proceeds from the IPO will fund preclinical and clinical development for Polyrizon’s innovative hydrogel product candidates, supporting further research and development (R&D). Polyrizon’s focus on intranasal protection aligns with a rapidly expanding market in drugdelivery innovation.
Interest in the pulmonary route has also grown in recent years because delivering the drugs through the lungs allows direct systemic delivery and bypasses the first pass metabolism. Why is pulmonary drugdelivery a complex challenge? How can we accomplish drugdelivery to the lungs in nonclinical studies?
Becton, Dickinson and Company (BD), a pioneer in medical technology, has issued a voluntary recall notice for a trio of their intraosseous access products. Intraosseous infusion of a drug is when a drug is administered into the bone marrow cavity which facilitates the delivery of the drug through a non-collapsible vein.
DrugDelivery Devices Symposium. We have the distinct privilege of unveiling Oxford Global’s DrugDelivery Devices Symposium, taking place on the 10th of March, 2021. Discuss Combination Product Development & Engineering with leading experts such as Andrew Yum , United Therapeutics and Ning Yu , Biogen.
Amazon Pharmacy launched a pair of TV spots last month to showcase the ease of its drugdelivery service for consumers. In 2023, it introduced RxPass , a prescription drug program that offers common drugs for a flat fee of $5. According to Statista , the global online pharmacy market is predicted to hit $82.42
SHL Medical is a world-leading solutions provider for advanced drugdelivery systems with a unified purpose to further enable patient independence. The company’s most prominent products are its autoinjectors, which are seeing growing global demand. It will be high-tech, fully automated production,” Turvill adds. “A
It has combined expertise in otology, gene therapy and inner ear drugdelivery to meet the requirements of individuals with disabling hearing loss globally. AK-OTOF is the lead product candidate of the company. It is a gene therapy intended to treat hearing loss due to otoferlin gene (OTOF) mutations.
Having reported over 70% increase in revenues over the past 5-6 years, the market for biologically derived products is currently estimated to be worth more than USD 200 billion. Our Social Media Platform Web: [link] LinkedIn: [link] Twitter: [link] The post Subcutaneous Medications and DrugDelivery Systems appeared first on Blog.
The main products used for toenail fungus treatment are available in most pharmacies, supermarkets and perhaps with the best range of products found online. Topical products, which are applied directly to the infected area, are the main products used as toenail fungus treatment.
Innovations in Formulation and Device Design for Enhanced Subcutaneous Delivery. As Part of Europe’s leading Injectable conference series, we will assess innovations in drugproduct formulation and biologics, new technologies in device design and the use of long-release injectable compounds. reaching £915 billion by 2027.
Over the last two decades, the pharmaceutical industry has observed a paradigm shift from conventional drugdelivery strategies to the long-acting drugdelivery (LADD) of products to treat several disease indications, such as ophthalmic disorders, oncological disorders, neurological disorders and infectious diseases.
We have put in our best effort to make it easily graspable what are the intracellular drugdelivery technologies and how it can ensure effective treatment for fatal disease. Below are the highlights that we feel would be helpful to understand about the intracellular drugdelivery / intracellular non-viral drugdelivery approach.
Workshop will be on ‘Ophthalmic DrugDelivery Development – Trials and Tribulations’. Ophthalmic DrugDelivery is compelling for many reasons, including the major issue of patient compliance and tolerability of therapies. Appreciating the science and art of formulating DD products. About the workshop leader.
Furthermore, a wide variety of drugs and macromolecules, including DNA , proteins, and imaging agents, can be encapsulated in liposomal vesicles due to their unique ability to entrap both lipophilic and hydrophilic substances. The various therapeutic applications of liposomes in drugdelivery have been highlighted in the figure.
DUBLIN–(BUSINESS WIRE)–The “Liposome DrugDelivery Market Forecast to 2027 – COVID-19 Impact and Global Analysis by Product; Application” report has been added to ResearchAndMarkets.com’s offering. The liposome drugdelivery market is expected to reach US$ 6,992.95
Global Inhaled and Intranasal Products 2020-2030: Contract Service Providers Market – Focus on Drugs and DrugDelivery Systems – ResearchAndMarkets.com Global Inhaled and Intranasal Products 2020-2030: Contract Service Providers Market – Focus on Drugs and DrugDelivery Systems – ResearchAndMarkets.com … Continue reading (..)
The 2023 Transdermal and Microneedle DrugDelivery Conference will explore real world applications of microneedles in drugdelivery and strategies for advanced and user-centric device design. Regulation of transdermal delivery systems will be another key theme addressed, in combination with clinical trial optimization.
Cellibre, a pioneer in sustainable biochemical manufacturing, has received a $2 million grant from the National Center for Complementary and Integrative Health (NCCIH) at the National Institutes of Health (NIH).
Aptar Enters into Agreement with Weihai Hengyu Medical Products to Add Elastomeric and Plastic Component Manufacturing Capabilities in China for Injectable DrugDelivery Aptar Enters into Agreement with Weihai Hengyu Medical Products to Add Elastomeric and Plastic Component Manufacturing Capabilities … Continue reading →
Therefore, medical technology is rapidly evolving, enabling more advanced and patient-friendly methods of drugdelivery. In the pursuit of creating patient-centric healthcare solutions, the medical industry has witnessed a groundbreaking advancement in drugdelivery with the emergence of large volume wearable injectors.
SLNs offer various benefits, such as easy production process, good release profile and low cost. However, their drawbacks include limited drug loading capacity and potential drug expulsion during storage. In addition, NLCs offer benefits such as high drug loading capacity, improved drug retention and avoidance of drug expulsion.
Satsuma shareholders will receive the CVR subject to the future sale, licence or any other monetisation events related to Satsuma’s new investigational therapeutic product, STS101. In March 2023, Satsuma submitted a new drug application for STS101 to the US Food and Drug Administration (FDA). in cash per share.
Elyxyb is a prescription nonsteroidal anti-inflammatory drug (NSAID) used for acute migraine treatment in adult patients with or without aura. It is formulated using a self-micro-emulsifying drugdelivery system that improves the drug’s bioavailability and solubility.
Antares Pharma overview Antares Pharma is a specialty pharmaceutical company engaged in the development, manufacturing, and commercialization of pharmaceutical products and technologies. It also develops products to reduce the risk of preterm birth in pregnant women.
IN-ARMOR will use computer-aided drug design and in silico approaches, as well as a nanotech-based drugdelivery system. An existing drug platform will also be optimised by the project for its first target indication. Once completed, the project will be advanced to clinical validation.
When it comes to vaccines and other high-value biologics, it is essential that effective formulations go hand in hand with safe delivery. This could equate to significant savings when considering the large-scale production and distribution of major vaccines. Lower materials usage and easier storage and disposal are further advantages.
The FDA has issued a warning about dosing errors and subsequent adverse events related to compounded semaglutide injectable products. These issues primarily stem from patients and healthcare providers miscalculating or incorrectly administering the drug. These errors have led to some patients being hospitalized due to overdoses.
The production of commercial dose non-sterile products such as tablets, capsules, ointments, creams, and powders is rising due to their growing global demand, attributed to increasing demand for anti-ageing products, hereditary factors, genetic mutations, exposure to harmful radiation, and rising geriatric population.
Research agreement to investigate the feasibility of a proprietary biotechnology process for the industrial production of psilocybin API.
XPhyto is currently focused on securing industrial scale production of psychedelic APIs and the standardization of drug formulations for the delivery of such APIs.
This will aid in the production of new raw materials and possible clinical-grade assets to develop mRNA vaccines and therapies for infectious diseases, as well as other ailments with unmet needs.
Bayer recently announced that it has received US Food and Drug Administration (FDA) clearance for its MEDRAD Centargo computed tomography (CT) injection system, a multi-patient injector that aims to improve workflow efficiency in CT imaging procedures.
Novaliq, a biopharmaceutical company specializing in ocular therapeutics, recently announced that their product Vevye (cyclosporine ophthalmic solution) 0.1 percent received approval from the US Food and Drug Administration (FDA) to treat dry eye disease. As a water-free product, it does not have an associated pH value or osmolarity.
Linker Stability : The stability of the linker, which attaches the chemotherapy agent to the antibody, is essential for efficient and precise drug-delivery. Researchers are actively looking for ways to solve these problems with the goal of finding the optimal balance between efficacy and toxicity for many of these drugs.
It also helps companies to reduce the costs associated with research and development and speed up the time to market new products. This will eventually aid the drug developers to accelerate drug development, improve drug efficacy and safety, and bring products to market faster, ultimately benefiting patients and healthcare systems.
This morning, Sandoz announced it has acquired medical and drugdelivery device specialist Coalesce Product Development, bolstering its capabilities for the development of respiratory medicines and ‘complex’ generics.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content